ArticleBMC cancer2026
Geographic and demographic patterns of cervical cancer in Africa using GLOBOCAN 2022.
Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cervical Cancer Knowledge, Attitudes, and Practices Among Informal Sector Women: Prevention Challenges in Eastern Democratic Republic of the Congo.International journal of women's health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundCervical cancer remains a significant public health challenge for women in Africa. This study aimed to quantify the current burden of cervical cancer across the continent using the most recent estimates from the Global Cancer Observatory (GLOBOCAN) 2022.
methodsData were obtained from GLOBOCAN 2022. Age-standardized incidence rates (ASIR) and age-standardized mortality rates (ASMR) per 100,000 person-years were calculated using direct standardization with the Segi–Doll world standard population. Pearson’s correlation analysis was applied to examine associations between the Human Development Index (HDI) and cervical cancer incidence and mortality. Future numbers of cases and deaths through 2050 were projected based on global population forecasts.
resultsIn 2022, an estimated 125,699 new cervical cancer cases and 80,614 deaths occurred in Africa. Nigeria recorded the highest numbers of incident cases (13,676) and deaths (7,093). The highest ASIR was observed in Eswatini (95.9 per 100,000), while Malawi exhibited the highest ASMR (54.1 per 100,000). Mortality rates increased progressively with age and rose sharply among individuals aged 75 years and older. A negative association was identified between HDI and mortality rates. Projections indicate that Nigeria and Tanzania will experience the largest future burden, with Equatorial Guinea, Tanzania, and Zambia facing increases exceeding 200% in incidence and 210% in mortality by 2050.
conclusionsCervical cancer mortality remains disproportionately high in countries with lower socioeconomic development. Targeted and timely interventions in these settings are essential to curb the projected escalation of disease burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.